Application of Pharmacoeconomics in Health Care Decision Making
|School||Shenyang Pharmaceutical University|
|Keywords||Pharmacoeconomics Health policy Decision making Application|
With the rapid increase of health care cost all of the world, the control of it play an important pole in every country’s health care system. The percentage of drug cost among health cost take up 10%-20% in developed countries, but in our country the percentage is up to 50%-60%. Recent years in order to settle the issues of "kanbinggui" and "yaojiaxugao", the State of Development and Reform Council decreased the drug price 22 times. All these reality told us, from the perspective of health care controlling drug cost and choosing the most appreciate therapy is the first important thing in our health care system. Based on all these background, the article links the concept of pharmacoeconomics and health policy and tries to establish a decision framework using PE.First, the article analyzes the characteristics of health care market and the reason of market failure; clarify the special function of PE in health care; demonstrate the social background PE coming forth; make clear that in order to solve the efficiency issues in health care, the application of PE is necessity. Then the article introduces how the international PE is developed. Second, PE theory and analysis method is demonstrated systematically. Although some methods is not developed in our country, but the using of advanced method is the base of scientific conclusion. We should know them comprehensively and systematically, thus we can draw out the advantage and disadvantage when application,Based on its social function and methods, the article uses the successful experience of the PE application in developed countries for reference. The article establishes the PE application framework in our country under the China’s realistic situation and health policy. Main points of the framework include the following three aspects. First, we should establish a PE evaluation organization in the structure of SFDA to serve for the decision of new drug application, drug reevaluation and the drug selection of State Essential Drug Formulary. Second, evaluate PE research when selection of State Medical Insurance Formulary in the Ministry of Labor and Social Surety and New Cooperative Medical Insurance Formulary in rural areas, when set the drug price in the State of Development and Reform Council; the article bring forward the examine procedure and approach. Third, the pharmaceutical company should apply PE concept into the whole drug life-circle including R&D, producing, wholesaling and utilization. The whole application framework can radically assistant health care industry decision process and promote it healthy growth.